Concomitant Kinase-Dead BRAF and Oncogenic KRAS Lead to an Aggressive Biologic Behavior and Tumor Lysis Syndrome: A Case Report

Tumor lysis syndrome (TLS) is a life-threatening oncological emergency rarely seen in solid tumors and is a complication of cancer therapy for rapidly proliferating tumors with devastating outcomes. BRAF and KRAS are two key oncogenes in the MAPK signaling pathway that are routinely examined for mut...

Descripción completa

Detalles Bibliográficos
Autores principales: Holland, Roy, Ben-Ishay, Offir, Ben-Aharon, Irit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108264/
https://www.ncbi.nlm.nih.gov/pubmed/35586494
http://dx.doi.org/10.3389/fonc.2022.885814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108264/
https://www.ncbi.nlm.nih.gov/pubmed/35586494
http://dx.doi.org/10.3389/fonc.2022.885814

Ejemplares similares